Pamela Fralick
Guest ContributorDecember 9, 2016
Pamela Fralick has been appointed president of Innovative Medicines (formerly Canada's Research-Based Pharmaceutical Companies - Rx&D) effective immediately. She replaces interim president Elaine Campbell who stepped in five months ago following the departure of Russell Williams. Fralick is a veteran health administrator who was previously president and/or CEO of the Canadian Cancer Society, Canadian Healthcare Association and Canadian Physiotherapy Association. She holds a Masters of Public Administration from Queen's Univ....
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 1 free article remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.